To honor a century and a half of serving humanity, Mayo Clinic has compiled a list of 150 medical contributions. The list includes innovations such as developing the concept of an integrated, multispecialty, not-for-profit group practice of medicine, establishing the first hospital-based blood bank in the United States, developing the ketogenic diet to help control epilepsy, and performing the first Food and Drug Administration (FDA) approved hip replacement in the United States.
In the July issue of Journal of Clinical Microbiology, Mayo Clinic representatives discuss how the Hepatitis/HIV Molecular Laboratory implemented Lean concepts to improve efficiency and operations.
Mayo Medical Laboratories president and chief executive officer Franklin Cockerill, M.D., recently announced that he is retiring from Mayo Clinic, effective at the end of September 2014.
Aug. 8th marks the 80th anniversary of Franklin Delano Roosevelt’s visit to Rochester to honor doctors Will and Charlie Mayo for their humanitarian work with disabled World War I veterans.
The July article, “Tackling Reagent Lot-to-Lot Verification,” in Clinical Laboratory News, written by Alicia Algeciras-Schimnich, Ph.D., associate professor of Mayo Clinic Laboratory Medicine and Pathology and director of Mayo’s Clinical Immunoassay Laboratory, discusses the importance of reagent lot performance verification.
We complete our #throwbackthursdays series on the founding generation of Mayo Clinic with the introduction of John Kahler, Arthur Sanford, M.D., and Joseph Fritsch.
The Star Tribune recaps the 21st Century Cures Roundtable on Personalized Medicine, featuring Franklin Cockerill, M.D., Chair of the Mayo Clinic Department of Laboratory Medicine and Pathology. Read this post for a summary of the discussion and key points from Dr. Cockerill on his views on personalized medicine.
On Wednesday morning, Frank Cockerill, M.D., participated in a roundtable discussion hosted by the U.S. House of Representatives Energy and Commerce Committee. Throughout Dr. Cockerill’s remarks, he emphasized the importance of providing proper government funding for research and regulatory bodies, harmonizing regulations, emphasizing clinical validation, ensuring patient safety, and encouraging innovation.
We are continuing our #throwbackthursdays series on the founding generation of Mayo Clinic. This week’s post introduces Maud Mellish, Mabel Root and Dr. Plummer.
In the May/June issue of Medical Lab Management, Jane Hermansen, MBA, MT(ASCP), network manager for Mayo Medical Laboratories, discusses using quality assurance (QA) in the laboratory.
We are kicking off a #throwbackthursdays series introducing the founding generation of Mayo Clinic. This week’s post introduces William Worrall Mayo, M.D., Dr. Charlie, Dr. Will, Dr. Gertrude Booker and Edith Graham, R.N.
For patients and employees alike, it’s common to hear that a surgeon operates on “orange days” or that a committee meets on the “second blue Tuesday” of each month. The story behind this designation provides a unique perspective on the Mayo Clinic decision-making process.
In Genetic Engineering & Biotechnology, David Smith, Ph.D., professor of laboratory medicine and pathology at the Mayo Clinic, discusses integrating and interpreting clinical genomics data.